MAPT and Alzheimer disease: Both GSK3β and GSK3α stimulates tau hyper-phosphorylation at both primed and non-primed phosphorylation sites, in both cell culture models, as well as in vitro models of neurodegeneration, further implicating GSK3 as a vital factor in AD [42,43].